SUBSIM Radio Room Forums - View Single Post

Skybird · 11-01-21, 05:06 PM

US company Novavax asks EU authorities for licensing its new vaccine, which is based on traditional vaccine technologies. Hope is it will convince vaccination sceptics who are not opposed against vaccination in principle, just against the suspected malicous seeds in new mRNA vaccines.

The vaccine is already allowed in Indonesia since short time. Novavax also seeks licensing in Canda, Australia, the US. Rolling reviews for it are done since February or January this year.

Early results from February raised hopes that a third booster jab with Novavax after two earlier mRNA jabs does boost number of antibodies by factors of 4 and higher.

11-01-21, 05:06 PM	#9041
Skybird Soaring Join Date: Sep 2001 Location: the mental asylum named Germany Posts: 40,660 Downloads: 9 Uploads: 0	US company Novavax asks EU authorities for licensing its new vaccine, which is based on traditional vaccine technologies. Hope is it will convince vaccination sceptics who are not opposed against vaccination in principle, just against the suspected malicous seeds in new mRNA vaccines. The vaccine is already allowed in Indonesia since short time. Novavax also seeks licensing in Canda, Australia, the US. Rolling reviews for it are done since February or January this year. Early results from February raised hopes that a third booster jab with Novavax after two earlier mRNA jabs does boost number of antibodies by factors of 4 and higher. __________________ If you feel nuts, consult an expert.